Almac Group Ltd

Almac is a global company that provides a range of services and products across the drug development lifecycle. The company's core business includes pharmaceutical development and manufacturing, diagnostic services, clinical services, and commercial services. Almac offers expertise in areas such as active pharmaceutical ingredient (API) manufacture, formulation development, clinical trial supply, and commercial-scale manufacturing and distribution. The company also provides diagnostic services, including genomic services, clinical biomarker development, and clinical testing. Additionally, Almac has a research-driven drug discovery arm, Almac Discovery, which develops novel and innovative therapeutics. Through its subsidiary, Galen, Almac also markets and distributes pharmaceuticals globally. With over 7,800 employees and 18 facilities worldwide, Almac partners with top biopharmaceutical companies to advance human health.

Almac provides the most comprehensive range of services extending from research through pharmaceutical and clinical development to commercialisation of product.

Over 600 companies worldwide, including all the market leaders, use our services, testament itself to the quality, innovation and efficiency of our business as proven over the past 30 years.

Biomarker Discovery & Development
API Services & Chemical Development
Pharmaceutical Development

Analytical Services
Clinical Trial Supply
Clinical Technologies
Commercial Services